N-hexanoyl-D-erythro-sphingosine

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 鞘脂
• 英文名称: N-hexanoyl-D-erythro-sphingosine
• 英文别名: N-[(E)-1,3-dihydroxyoctadec-4-en-2-yl]hexanamide
• 化学式: C₂₄H₄₇NO₃
• 分子量: 397.6
• InChiKey: NPRJSFWNFTXXQC-VHEBQXMUSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  7.5
• 重原子数：
  28
• 可旋转键数：
  20
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.88
• 拓扑面积：
  69.6
• 氢给体数：
  3
• 氢受体数：
  3

文献信息

• Method And Compositions For Improving Selective Catabolysis And Viability In Cells Of Keratin Surfaces
  申请人：ELC Management LLC

  公开号：US20140193391A1

  公开（公告）日：2014-07-10

  A composition for treating keratin surfaces to stimulate selective catabolysis and improve cellular viability comprising at least one autophagy activator and at least one DNA repair enzyme, and a method for improving selective catabolysis and cellular viability by treating with the composition.

  一种用于处理角蛋白表面以刺激选择性分解并改善细胞生存能力的组合物，包括至少一种自噬激活剂和至少一种DNA修复酶，以及一种通过使用该组合物来改善选择性分解和细胞生存能力的方法。
• [EN] IDENTIFICATION OF NSC23925 ISOMERS TO REVERSE MULTIDRUG RESISTANCE IN HUMAN CANCERS<br/>[FR] IDENTIFICATION D'ISOMÈRES NSC23925 POUR INVERSER LA RÉSISTANCE MULTIPLE AUX MÉDICAMENTS DANS DES CANCERS HUMAINS
  申请人：GEN HOSPITAL CORP

  公开号：WO2013126664A1

  公开（公告）日：2013-08-29

  This disclosure features optically active stereoisomers of (2-(4-methoxy)quinolin-4-yl)(piperidin-2-yl)methanol that reduce drug resistance, compositions containing the same, and methods of using and preparing the same.

  本公开涉及具有光学活性的立体异构体(2-(4-甲氧基)喹啉-4-基)(哌啶-2-基)甲醇，可降低药物耐药性，包含相同的组合物，以及使用和制备相同的方法。
• DIHYDROCERAMIDE DESATURASE INHIBITORS.
  申请人：CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS

  公开号：EP1354870A1

  公开（公告）日：2003-10-22

  Cyclopropenylceramide derivatives as inhibitors of desaturases characterized by the general formula I in which R1 can be an alkyl, alkenyl, alkynyl, aryl or any heterocyclic group, n can have any value and it can be branched or straight chained and can contain unsaturated carbons and R2 and R3 can have the same or different values, and it can represent aryl, heteroaryl, alkyl or acyl groups with one or more unsaturated carbons on the chain, that can be branched or straight and substituted with OH groups. Members of this new class of compounds have shown an extraordinary activity as inhibitors of the dihydroceramide desaturase and of ceramide biosynthesis and are useful for the treatment of clinical conditions associated with increased intracellular ceramide.

  环丙烯基鞘氨醇衍生物作为脱饱和酶抑制剂，其一般式为I，其中R1可以是烷基，烯基，炔基，芳基或任何杂环基团，n可以有任何值，可以是支链或直链，可以含有不饱和碳，并且R2和R3可以具有相同或不同的值，并且可以表示带有一个或多个链上不饱和碳的芳基，杂环芳基，烷基或酰基基团，可以是支链或直链，并且可以用OH基团取代。这种新类化合物的成员已经表现出极高的脱氢鞘氨醇酰酶和鞘氨醇生物合成抑制活性，并且对于治疗与细胞内鞘氨醇增加有关的临床病症非常有用。
• Functional associative coatings for nanoparticles
  申请人：Hainfeld James F.

  公开号：US20080089836A1

  公开（公告）日：2008-04-17

  Described herein are nanoparticles that are coated with a bilayer of molecules formed from surface binding molecules and amphiphatic molecules. The bilayer coating self assembles on the nanoparticles from readily available materials/molecules. The modular design of the bilayer coated nanoparticles provides a means for readily and efficiently optimizing the properties of the bilayer coated nanoparticle compositions. Also described herein are uses of such nanoparticles in medicine, laboratory techniques, industrial and commerical applications.

  本文描述了一种纳米颗粒，其表面涂覆有由表面结合分子和两亲分子形成的双层分子层。该双层涂层可以自组装在纳米颗粒上，使用易得的材料/分子。双层涂层纳米颗粒的模块化设计提供了一种方便和高效地优化其性质的方法。此外，本文还描述了这种纳米颗粒在医学、实验室技术、工业和商业应用中的用途。
• Induction of blood vessel formation through administration of polynucleotides encoding sphingosine kinases
  申请人：Novartis AG

  公开号：US20040086487A1

  公开（公告）日：2004-05-06

  A method of inducing blood vessel formation in an animal by administering to the animal a polynucleotide encoding a sphingosine kinase, or an analogue, fragment, or derivative thereof. The polynucleotide may be contained in an appropriate expression vector, such as a viral vector. The delivery of sphingosine kinase through administration of an expression vector which expresses sphingosine kinase provides for the formation of larger blood vessels containing a well defined structure that is supported by mural cells such as pericytes and smooth muscle cells.

  通过给动物注射编码鞘氨醇激酶的多核苷酸，或其类似物、片段或衍生物，诱导动物形成血管的方法。多核苷酸可以包含在适当的表达载体中，例如病毒载体。通过注射表达鞘氨醇激酶的表达载体，提供了形成较大血管的机会，这些血管包含由包括血管周细胞和平滑肌细胞在内的壁细胞支持的明确定义的结构。